An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention
Article first published online: 24 SEP 2010
© 2010 Wiley Periodicals, Inc.
Volume 23, Issue 5, pages 458–476, September/October 2010
How to Cite
Forcier, M. and Musacchio, N. (2010), An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention. Dermatologic Therapy, 23: 458–476. doi: 10.1111/j.1529-8019.2010.01350.x
- Issue published online: 24 SEP 2010
- Article first published online: 24 SEP 2010
- cervical cancer;
- genital warts;
- human papillomavirus;
Genital human papillomavirus (HPV) is a common, usually transient, dermatologic infection transmitted by genital contact that can cause a variety of anogenital diseases, including warts (condyloma), dysplasia (cervical, vaginal, vulvar, anal), and squamous cell carcinoma. A number of treatment modalities are available to treat anogenital warts, both patient- and provider-applied.
Treatment is efficacious, but lesions can recur. Bivalent and quadrivalent vaccines are approved to prevent HPV infection. Both are indicated to prevent cervical cancer, while the quadrivalent vaccine is also approved to prevent vaginal/vulvar cancers as well as genital warts in males and females. Providers should clearly explain the natural history and potential sequelae of HPV disease, counsel patients on prevention strategies, and recommend vaccination as an effective method of prevention to their patients.